July 25 (Reuters) - Atai Life Sciences (9VC.DE), opens new tab and its partner Recognify Life Sciences said on Friday their experimental drug did not meet the main goal in a mid-stage trial for ...

Joshua Kaufman, MD, of CDPHP, discusses the significance of long-acting injectables (LAIs) in improving adherence, reducing the risk of relapse, and preventing hospitalizations. If a patient has a ...

atai Life Sciences (ATAI) company Recognify Life Sciences has reported that its Phase IIb trial of oral compound, inidascamine, to treat cognitive impairment associated with schizophrenia (CIAS) ...

Managed by Harmony Bay Wellness. Your call or email may go to a representative. Struggling with anxiety, mood disorders, or schizophrenia? Finding it challenging to manage your mental health despite ...

German drugmaker Boehringer Ingelheim and Click Therapeutics said their phase 3 trial of a prescription digital therapeutic for the negative symptoms of schizophrenia met its primary endpoint. Data ...

CLEVELAND, Ohio (May 7, 2025)—Many women struggle to find resources to help manage their menopause symptoms. For women living with a serious mental illness, the need for additional support and ...